Skip Ribbon Commands
Skip to main content
Sign In
News St. Mary's Becomes First Hospital in Madison to Offer Patients a New Heart Failure Monitoring Solution

St. Mary's Becomes First Hospital in Madison to Offer Patients a New Heart Failure Monitoring Solution

5 Million Americans Have Heart Failure, With 670,000 New Cases Diagnosed Each Year

Madison ,
WI
1/5/2016

​​St. Mary’s Hospital is the first in the Madison area to implant a new wireless monitoring sensor to manage heart failure. The CardioMEMS HF System is the first and only FDA-approved heart failure monitoring device that has been proven to significantly reduce hospital admissions when used by physicians to manage heart failure.

The CardioMEMS HF System features a sensor that​ is implanted in the pulmonary artery (PA) during a non-surgical procedure to directly measure PA pressure. Increased PA pressures appear before weight and blood pressure changes, which are often used as indirect measures of worsening heart failure. The new system allows patients to transmit daily sensor readings from their homes to their health care providers allowing for personalized and proactive management to reduce the likelihood of hospitalization.

“Heart failure occurs when the heart is unable to pump enough blood to meet the body’s demands,” says Dr. John Phelan, a Dean & St. Mary’s Cardiologist who has performed the procedure on two patients so far. “Patients with heart failure are frequently hospitalized, have a reduced quality of life and face a higher risk of death. The CardioMEMS device provides clinicians with the ability to detect worsening heart failure sooner and adjust treatment to reduce the likelihood that the patient will need to be hospitalized. The device has been demonstrated to reduce the risk of hospitalization and mortality, thereby improving the quality of life.”

According to the American Heart Association, the estimated direct and indirect cost of heart failure in the U.S. for 2012 was $31 billion and that number is expected to more than double by 2030. Over half of heart failure costs are due to hospitalization and there are more than 1 million heart failure admissions each year. By 2030, every U.S. taxpayer could pay $244 each year for heart failure expenses.

The CardioMEMS HF System, from global medical device manufacturer St. Jude Medical, is approved by the U.S. Food and Drug Administration (FDA) for commercial use in the U.S. For more information, visit http://www.heartfailureanswers.com/